⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMAB News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of I-Mab - IMAB
prnewswire.com
IMAB
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
globenewswire.com
IMAB
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
prnewswire.com
GTBP
GDTC
PSTV
IOVA
IMAB
GTBP
GDTC
PSTV
IOVA
IMAB
I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
globenewswire.com
IMAB
Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms
prnewswire.com
GTBP
IMAB
ENGN
ONCO
NBTX
GTBP
IMAB
ENGN
ONCO
NBTX